Nektar Therapeutics

IRS: 943134940
NKTR
Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.

Founded
1990 (32 years)
Investor RelationsSEC
Revenue
126 million (2021)

Want to see more? Sign up!